Valuation : LifeMD, Inc.

Market Cap 148M 128M 120M 110M 205M 14.04B 206M 1.42B 550M 7.19B 558M 545M 22.9B P/E 2026 *
-5.94x
P/E 2027 * -58.3x
Enterprise Value 148M 128M 120M 110M 205M 14.04B 206M 1.42B 550M 7.19B 558M 545M 22.9B EV / Sales 2026 *
0.72x
EV / Sales 2027 * 0.61x
Free-Float
85.13%
Yield 2026 *
-
Yield 2027 * -
1 day-1.01%
1 week+0.43%
Current month+0.43%
1 month-0.90%
3 months-1.48%
6 months+3.33%
Current year+5.49%
1 week 23
Extreme 23
23.5
1 month 23
Extreme 23
23.96
Current year 21.9
Extreme 21.9
24.2
1 year 18.5
Extreme 18.5
24.2
3 years 17.15
Extreme 17.15
27.44
5 years 12.6
Extreme 12.6
27.44
10 years 12.6
Extreme 12.6
27.44
Manager TitleAgeSince
Chief Executive Officer 39 2025-07-31
Director of Finance/CFO 57 2026-03-15
Chief Tech/Sci/R&D Officer - 2026-05-31
Director TitleAgeSince
Chairman 65 -
Director/Board Member 75 2014-09-03
Chairman 43 2019-06-10
Change 5-day change 1-year change 3-year change Capi.($)
-1.01%+0.43% - - 148M
-3.27%-3.71%+0.79%+23.91% 44.54B
+0.23%-4.15%-43.54%+132.06% 12.71B
-3.51%-5.08%-15.30%+75.34% 5.63B
-1.61%-2.94%+57.42% - 4.25B
+0.31%+7.33% - - 2.1B
-1.29%-2.25%+7.04%-38.11% 1.57B
+1.93%-0.76%-34.42% - 1.08B
+0.59%+1.38%+22.62%+147.60% 1.02B
-1.83%-8.29%+39.00%+47.04% 915M
Average -0.94%-1.62%+4.20%+64.64% 8.2B
Weighted average by Cap. -2.29%-3.41%-4.57%+49.74%

Financials

2026 *2027 *
Net sales 208M 178M 168M 153M 287M 19.63B 288M 1.99B 769M 10.05B 779M 762M 32.02B 245M 211M 198M 181M 338M 23.17B 339M 2.35B 908M 11.87B 920M 900M 37.8B
Net income -24.83M -21.35M -20.08M -18.33M -34.28M -2.35B -34.4M -238M -92.04M -1.2B -93.24M -91.2M -3.83B -2.68M -2.3M -2.16M -1.98M -3.69M -253M -3.71M -25.66M -9.92M -130M -10.05M -9.83M -413M
Net Debt - -
Logo LifeMD, Inc.
LifeMD, Inc. is a patient-centric, direct-to-patient healthcare company. The Company is engaged in providing patients access to virtual medical care and pharmacy services. Its telehealth platform helps patients access licensed providers for diagnoses, virtual care, and prescription medications, often delivered on a recurring basis and sells over the counter (OTC) products. Its products are available on a subscription or membership basis, where a patient can subscribe to receive regular shipments of prescribed medications or products. The Company's men's brand, RexMD, offers access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation and hair loss. Its vertically integrated care model combines technology, affiliated clinical services, pharmacy infrastructure, and artificial intelligence (AI)-enabled operational systems to deliver longitudinal care.
Employees
350
Date Price Change Volume
26-09-04 US$23.25 -1.01% 228
26-09-03 US$23.49 -0.05% 1,649
26-09-02 US$23.50 -0.47% 2,798
26-09-01 US$23.61 +2.00% 4,444
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
3.080USD
Average target price
8.125USD
Spread / Average Target
+163.80%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!